This research study is studying nivolumab, an investigational drug, in combination with
ipilimumab, also an investigational drug, as a possible treatment for thyroid cancer.
The drugs involved in this study are:
- Nivolumab (Opdivo™)
- Ipilimumab (Yervoy™)